1. [email protected] : bappi : bappi
  2. [email protected] : Admin : Admin
Forbes ranks Beximco, Square Pharma in Asia's Top 200 companies
Sunday, 06 October 2024, 04:29 am

Forbes ranks Beximco, Square Pharma in Asia’s Top 200 companies

  • Update Time : Thursday, 23 November, 2023, 06:06 pm
  • 143 Time View

Online Desk: Square Pharmaceuticals and Beximco Pharmaceuticals, two leading pharmaceutical companies in Bangladesh, has been listed in Forbes Magazine’s “Asia’s 200 Best Under a Billion” for the year 2023.

The list, published yearly by the US-based Forbes Magazine, selects top 200 publicly listed companies in the Asia-Pacific region with sales under $1 billion, based on their robust corporate performance from a pool of over 20,000 small and mid-sized businesses across the Asia-Pacific region.

Square Pharmaceuticals, showcased a sale of $646 million, net income of $210 million, and a significant market value of $2.04 billion, while Beximco Pharmaceuticals reported sales of $319 million, a net income of $47 million, and a market value of $600 million, according to Forbes.

Facebook Comments Box
More News Of This Category